Literature DB >> 27159170

HLA disparity is not inconsequential in peripheral blood T-replete haploidentical hematopoietic stem cell transplantation.

A Rashidi1, J F DiPersio1, P Westervelt1, C N Abboud1, M A Schroeder1, I Pusic1, A F Cashen1, T A Fehniger1, R Romee1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27159170     DOI： 10.1038/bmt.2016.117

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

Review 1.  Cyclophosphamide-induced immunological tolerance: an overview.

Authors:  H Mayumi; M Umesue; K Nomoto
Journal:  Immunobiology       Date:  1996-07       Impact factor: 3.144

2.  The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation.

Authors:  Ming-Rui Huo; Lan-Ping Xu; D Li; Dai-Hong Liu; Kai-Yan Liu; Huan Chen; Wei Han; Yu-Hong Chen; Y Wang; Jing-Zhi Wang; Xiao-Hui Zhang; Xiang-Yu Zhao; Xiao-Jun Huang
Journal:  Clin Transplant       Date:  2011-09-15       Impact factor: 2.863

3.  Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index.

Authors:  Asad Bashey; Xu Zhang; Katelin Jackson; Stacey Brown; Michelle Ridgeway; Melhem Solh; Lawrence E Morris; H Kent Holland; Scott R Solomon
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-07       Impact factor: 5.742

4.  Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.

Authors:  Yvette L Kasamon; Leo Luznik; Mary S Leffell; Jeanne Kowalski; Hua-Ling Tsai; Javier Bolaños-Meade; Lawrence E Morris; Pamela A Crilley; Paul V O'Donnell; Nancy Rossiter; Carol Ann Huff; Robert A Brodsky; William H Matsui; Lode J Swinnen; Ivan Borrello; Jonathan D Powell; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2010-01-18       Impact factor: 5.742

5.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Authors:  Leo Luznik; Paul V O'Donnell; Heather J Symons; Allen R Chen; M Susan Leffell; Marianna Zahurak; Ted A Gooley; Steve Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; Javier Bolaños-Meade; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742
  5 in total
  2 in total

1.  HLA epitope mismatch in haploidentical transplantation is associated with decreased relapse and delayed engraftment.

Authors:  Joseph Rimando; Michael Slade; John F DiPersio; Peter Westervelt; Feng Gao; Chang Liu; Rizwan Romee
Journal:  Blood Adv       Date:  2018-12-26

2.  The Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Score for HLA Class I Graft-versus-Host Disparity Is Associated with Increased Acute Graft-versus-Host Disease in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.

Authors:  Joseph Rimando; Michael Slade; John F DiPersio; Peter Westervelt; Feng Gao; Chang Liu; Rizwan Romee
Journal:  Biol Blood Marrow Transplant       Date:  2019-09-26       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.